"Colchicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE).
| Descriptor ID |
D003078
|
| MeSH Number(s) |
D03.132.225
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Colchicine".
Below are MeSH descriptors whose meaning is more specific than "Colchicine".
This graph shows the total number of publications written about "Colchicine" by people in this website by year, and whether "Colchicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colchicine" by people in Profiles.
-
Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2024 Apr 17; 14(4):e074373.
-
Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Europace. 2023 07 04; 25(7).
-
A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies. Pharmacotherapy. 2022 04; 42(4):320-333.
-
Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold. Bioorg Med Chem. 2021 01 01; 29:115874.
-
Managing acute and recurrent idiopathic pericarditis. JAAPA. 2020 Jan; 33(1):16-22.
-
Pharmacotherapeutic Management Strategies for Thyroid Disease-Induced Pericarditis. Ann Pharmacother. 2020 05; 54(5):486-495.
-
Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the USA. Am J Cardiovasc Drugs. 2015 Oct; 15(5):295-306.
-
Pharmacotherapy update of acute idiopathic pericarditis. Pharmacotherapy. 2015 Jan; 35(1):99-111.
-
Quantitation of "autophagic flux" in mature skeletal muscle. Autophagy. 2010 Oct; 6(7):929-35.
-
Advances in the management of gout and hyperuricaemia. Scand J Rheumatol. 2006 Jul-Aug; 35(4):251-60.